List view / Grid view
Researchers in Spain provide specific examples of metabolomics applications in the field of clinical pharmacology and precision medicine, focusing on the therapeutic management of cancer.
Scientists have become the first in the world to test how pathogens interact with artificial human organs...
Experimental activation of a small set of nerve cells in the brain prevents convulsive seizures in a mouse model of temporal lobe epilepsy.
Scientists have identified a gene that may play a protective role in preventing heart disease...
Scientists have designed a new machine learning algorithm that uses time-series data to uncover underlying biological networks.
DETECTR system allows quick, one-step detection and diagnosis of disease, infection...
Researchers have detailed a molecular atlas of the cells that form the brain's blood vessels and the life-essential blood-brain barrier providing clues to which cell types are involved in different diseases...
Researchers at the have identified a small drug molecule that can clear the herpes simplex virus-1 infection, making it a promising potential option for patients who have developed resistance...
The 13th annual World Advanced Therapies & Regenerative Medicine Congress brings together 1000+ attendees and explores the rapidly developing world of next generation therapeutics and ATMPS.
Scientists have used molecular simulations to understand the resistance to osimertinib - an anticancer drug used to treat types of lung cancer...
A team of researchers from the have found that gradually depleting an enzyme called BACE1 completely reverses the formation of amyloid plaques in the brains of mice with Alzheimer's disease...
Researchers report the successful use of heart imaging to predict the benefit or futility of catheter ablation...
Scientists from UNC-Chapel Hill and Princeton University in the United States, reveal key molecular details that hold promise for ultimate goal of heart disease reversal.
A novel approach to studying cancer has enabled researchers to group about 10,000 human cancers of 32 different types into 10 classes based on the molecular pathways that drive tumour growth.
NIH scientists have modified an assay to offer the possibility of improving early diagnosis of Parkinson’s disease and dementia with Lewy bodies...
